Since 2000, the percentage of S&P and Fortune 500 companies with a sitting COO has fallen from 48 percent to about 30 percent, according to WSJ, which cited the 2016 Crist|Kolder Volatility Report.
Peter Crist, chairman for Crist|Kolder, told WSJ the COO’s role is diminishing, as CFOs transition into more strategic roles focused on operations as well as financial planning.
More articles on healthcare finance:
A state-by-state breakdown of 76 rural hospital closures
35 NJ hospitals sued over tax-exempt status
Presence Health closes on $1B bond sale
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
